Related Experiment Videos
Update on chronic hepatitis C
1Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, Calif., USA.
Comprehensive Therapy
|March 3, 2004
Summary
Diagnosis and treatment for chronic hepatitis C are advancing. Selective liver biopsy and the peginterferon plus ribavirin combination are now standard approaches for most patients.
Area of Science:
- Hepatology
- Infectious Diseases
- Gastroenterology
Background:
- Chronic hepatitis C (HCV) management strategies are evolving.
- Traditional diagnostic and treatment paradigms are being reassessed.
Purpose of the Study:
- To outline current, evolving strategies for diagnosing and treating chronic hepatitis C.
- To highlight shifts in diagnostic approaches and preferred therapeutic regimens.
Main Methods:
- Review of current clinical practices and treatment guidelines for chronic hepatitis C.
- Analysis of the role of liver biopsy in contemporary HCV management.
- Evaluation of combination antiviral therapy.
Main Results:
- Liver biopsy is increasingly utilized selectively, not routinely, in chronic hepatitis C diagnosis.
- The combination therapy of peginterferon and ribavirin is established as the primary treatment for most patients.
- Evolving diagnostic and therapeutic landscapes offer improved patient management.
Conclusions:
- Current chronic hepatitis C management emphasizes selective diagnostic procedures.
- Peginterferon plus ribavirin combination therapy represents the current standard of care for the majority of patients.
- Ongoing advancements in hepatitis C treatment promise further improvements in patient outcomes.